title: Fatal pulmonary fibrosis after a low cumulated dose of bleomycin: role of alpha1-antitrypsin deficiency?
authors.forename: C
authors.initials: C
authors.lastname: Alliot
authors.forename: S
authors.initials: S
authors.lastname: Tabuteau
authors.forename: B
authors.initials: B
authors.lastname: Desablens
authors.forename: P
authors.initials: P
authors.lastname: Aubry
authors.forename: M
authors.initials: M
authors.lastname: Andrejak
mesh_terms: D000964:Antimetabolites, Antineoplastic / Q000009:adverse effects*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000009:adverse effects*; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D008875:Middle Aged; D011658:Pulmonary Fibrosis / Q000139:chemically induced*; D019896:alpha 1-Antitrypsin Deficiency / Q000150:complications*
chemical_list: D000964:Antimetabolites, Antineoplastic; D001761:Bleomycin